A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

December 31, 2005

Conditions
Restless Legs Syndrome
Interventions
DRUG

ropinirole

Trial Locations (37)

11040

GSK Investigational Site, New Hyde Park

14226

GSK Investigational Site, Amherst

19444

GSK Investigational Site, Lafayette Hill

21702

GSK Investigational Site, Frederick

27607

GSK Investigational Site, Raleigh

29201

GSK Investigational Site, Columbia

33026

GSK Investigational Site, Pembroke Pines

33606

GSK Investigational Site, Tampa

33701

GSK Investigational Site, St. Petersburg

33773

GSK Investigational Site, Largo

35007

GSK Investigational Site, Alabaster

35501

GSK Investigational Site, Jasper

45219

GSK Investigational Site, Concinnati

48025

GSK Investigational Site, Bingham Farms

60007

GSK Investigational Site, Elk Grove Village

60422

GSK Investigational Site, Flossmoor

60611

GSK Investigational Site, Chicago

66606

GSK Investigational Site, Topeka

70808

GSK Investigational Site, Baton Rouge

73112

GSK Investigational Site, Oklahoma City

75093

GSK Investigational Site, Plano

78229

GSK Investigational Site, San Antonio

78756

GSK Investigational Site, Austin

85032

GSK Investigational Site, Phoenix

87106

GSK Investigational Site, Albuquerque

87108

GSK Investigational Site, Albuquerque

90277

GSK Investigational Site, Redondo Beach

90404

GSK Investigational Site, Santa Monica

91325

GSK Investigational Site, Northridge

93030

GSK Investigational Site, Oxnard

98801

GSK Investigational Site, Wenatchee

99362

GSK Investigational Site, Walla Walla

85381 - 4828

GSK Investigational Site, Peoria

06824

GSK Investigational Site, Fairfield

02459

GSK Investigational Site, Newton

GSK Investigational Site, Newton Center

08818

GSK Investigational Site, Edison

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY